Advertisement
Synopsis

Synopsis PLOS Medicine published a Synopsis with every Research Article until May 2006. An Editors' Summary aimed at all medical professionals, whatever their specialty, and the general public, is now published at the end of each Research Article.

See all article types »

How Tumor Cells Acquire Resistance to Kinase Inhibitors

  • Published: February 22, 2005
  • DOI: 10.1371/journal.pmed.0020074

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

William Pao, Vincent A Miller, Katerina A Politi, Gregory J Riely, Romel Somwar, Maureen F Zakowski, Mark G Kris, Harold Varmus
Research Article | published 22 Feb 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020073

EGFR Inhibition in Non-Small Cell Lung Cancer: Resistance, Once Again, Rears Its Ugly Head

Jennifer Clark, Jan Cools, D. Gary Gilliland
Perspective | published 22 Feb 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020075